1. What Classification Risks Do Derivatives, Equities, and Structured Products Create?
Classification of a derivative or structured product determines which regulatory regime governs it, what capital reserves apply, and what disclosure obligations your firm must meet. The SEC and CFTC have overlapping and sometimes conflicting authority, and misclassification can trigger enforcement action, customer restitution orders, or both. Courts and regulators focus on the economic substance of the instrument, not merely its label, so a product marketed as an equity-linked note may be reclassified as a security or a derivative depending on its embedded features.
How Do Sec and Cftc Jurisdictional Lines Create Exposure?
The SEC generally regulates securities and security-based swaps; the CFTC regulates commodity futures and swaps. A structured product containing both equity and commodity components may fall under both regimes, creating overlapping compliance obligations. In practice, these cases are rarely as clean as the statute suggests. For example, a structured note linked to an equity index and a commodity basket may require SEC registration as a security, while simultaneously triggering CFTC swap dealer registration for the issuer. The consequences of getting this wrong include mandatory unwind of customer positions, disgorgement of profits, and civil penalties.
What Role Does New York State Law Play in Disputes?
Many derivatives and structured products disputes are litigated in the U.S. District Court for the Southern District of New York or in New York state courts under New York General Obligations Law Section 5-1401 (choice of law provisions in financial contracts). SDNY judges have extensive experience with derivatives disputes and apply a pragmatic approach to contract interpretation, focusing on the parties' intent and market practice rather than rigid textual parsing. New York courts recognize the sophistication of institutional parties and enforce netting agreements and collateral arrangements that might be scrutinized more heavily in other jurisdictions. This procedural context means that how you document your transaction, what representations you make, and how clearly you define settlement and valuation mechanics all carry significant weight in eventual disputes.
2. How Should Your Organization Address Valuation and Disclosure Transparency?
Valuation disputes are among the most frequent sources of litigation in derivatives and structured products. Clients often challenge the prices at which their positions are marked, the models used to calculate fair value, and whether the firm disclosed the limitations of those models. Regulators increasingly require that firms document their valuation methodologies, test them against market data, and disclose material model assumptions to customers. The risk intensifies when market conditions move sharply, because customers who experience losses want to understand whether the valuation was accurate or whether the firm concealed model limitations.
What Disclosure Obligations Apply to Structured Products?
For structured products sold to retail or institutional customers, you must disclose the material risks, including credit risk of the issuer, liquidity risk, and the impact of early termination features. The SEC's guidance emphasizes that disclosure must be clear and not buried in dense legal text. Courts have held that omitting or understating a material risk, even if technically disclosed in a footnote, can support a fraud claim. A practical scenario: a structured note linked to an emerging market index carries both market risk and issuer credit risk; if your disclosure emphasizes the upside potential but minimizes the credit risk in smaller type, a court may find that the disclosure was misleading despite being technically present.
3. What Counterparty and Collateral Risks Require Immediate Attention?
Counterparty credit risk is the risk that the other party to a derivatives transaction will fail to perform. In derivatives, equities, and structured products, this risk is often overlooked until a counterparty becomes distressed. Your firm should have documented collateral arrangements, including initial margin, variation margin, and haircut policies. These arrangements must comply with regulatory requirements under the Dodd-Frank Act and, for centrally cleared derivatives, must follow clearinghouse rules. The legal risk arises when collateral agreements are ambiguous, when margin calls are disputed, or when a counterparty challenges the valuation method used to determine margin requirements.
How Should Collateral Documentation Be Structured?
Collateral arrangements for derivatives transactions are typically governed by a Credit Support Annex (CSA) attached to an ISDA Master Agreement. The CSA must specify the types of collateral accepted, the haircuts applied, the frequency of margin calls, and the procedures for dispute resolution. Many firms use standard ISDA templates, but customization is common and often creates ambiguity. Courts interpreting CSAs focus on whether the parties clearly agreed to the calculation method and whether the margin calls were timely and mathematically correct. A dispute over margin methodology can freeze liquidity and escalate quickly into litigation. As counsel, I often advise clients to review their CSA language annually and to ensure that their margin calculation systems are audited and documented, so that margin calls can be defended if challenged.
4. What Compliance and Documentation Gaps Should You Audit Now?
Most enforcement actions and litigation losses stem not from a single transaction but from systemic gaps: inadequate documentation, inconsistent valuation practices, or incomplete disclosures across a product line. The SEC and CFTC routinely examine whether firms have written policies for classification, valuation, and disclosure, and whether those policies are actually followed. A compliance audit should identify whether your firm is:
- Documenting the basis for classification decisions and updating that basis if regulations change
- Maintaining contemporaneous records of valuation models and the assumptions underlying them
- Capturing all material representations made to customers in sales communications
- Recording margin calculations and collateral movements in a format that can be audited
These gaps are not theoretical. Regulators often impose remediation orders requiring firms to hire outside auditors, revalue customer positions, and make restitution payments. The cost of a proactive audit now is far lower than the cost of a regulatory examination or customer litigation later.
5. What Strategic Steps Should You Take before the Next Market Stress?
Market volatility tends to expose classification and valuation weaknesses. When prices move sharply, customers demand transparency, regulators scrutinize disclosures, and counterparties challenge margin calculations. Your organization should now assess whether your documentation, valuation systems, and disclosure practices will withstand that scrutiny. Consider engaging outside counsel to review your CSA templates, your product disclosure materials, and your valuation methodology documentation. Test your collateral calculation systems against historical stress scenarios. Confirm that your compliance team understands the regulatory classification of each product line and that your sales team is using consistent, audited disclosure language. These steps are not optional; they are the foundation of a defensible derivatives, equities, and structured products practice. For detailed guidance on specific product structures, consult resources on derivatives and structured products and understand how product design interacts with regulatory classification. Similarly, if your products contain physical or embedded components that could trigger product liability exposure, review the firm's position on defective products liability frameworks.
30 Mar, 2026
